|
Dr. Egorov is recognized nationally and internationally for his work in radiochemistry radioanalytical chemistry analytical chemistry and instrumentation. Prior to joining IsoRay in December of 2005 as Director of Radiochemical Development Dr. Egorov had worked as a Senior Research Scientist at the Pacific Northwest National Laboratory (PNNL). During his tenure at PNNL Dr. Egorov had led world-class basic and applied R&D programs directed at new chemistries and instrumentation for automated production of short-lived medical isotopes for the treatment of cancer automated process monitoring radionuclide sensors for groundwater monitoring and laboratory automation. Dr. Egorov pioneered the application of flow-based techniques for automating radiochemical analyses of nuclear wastes renewable surface sensing and separations and equilibration-based radionuclide sensing. He had authored/co-authored numerous peer-reviewed publications in these areas including several book chapters. Dr. Egorov holds four U.S./international patents three of which have been licensed to industry. Dr. Egorov was a recipient of numerous outstanding performance and key contributor awards. In 2003 Dr. Egorov was nominated for the American Chemical Society Arthur F. Findeis Award for Achievements by a Young Analytical Scientist. In 2004 Dr. Egorov was a recipient of a Federal Laboratory Consortium Award for Excellence in Technology Transfer for Alpha Particle Immunotherapy for Treating Leukemia and Solid-Tumor Metastases. Dr. Egorov holds a M.S. in Radiochemistry from Moscow State University Moscow Russia; a M.S. in Environmental and Analytical Chemistry and a Ph.D. in Analytical Chemistry from the University of Washington. | 